Tarsus Pharmaceuticals, Inc. TARS Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s cash ratio?
- Tarsus Pharmaceuticals, Inc. (TARS) reported cash ratio of 0.7× in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s cash ratio changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s cash ratio decreased by 64.9% year-over-year, from 2.1× to 0.7×.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s cash ratio has grown at a -46.5% compound annual growth rate (CAGR), from 31.2× to 1.4×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.